SEVERE ATOPIC DERMATITIS/ECZEMA A - REVIEW OF THE LITERATURE

被引:0
作者
Gouws, Annemarie
机构
关键词
ECZEMA; PREVALENCE; CHILDREN; TRIAL; SUPPLEMENTATION; AZATHIOPRINE; ADULTS; ACID;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Severe atonic dermatitis/eczema (SADE) is an uncommon and potentially debilitating condition with the tendency to follow a persistent course under certain circumstances. Confirmation of the diagnosis and assessment of the extent of impairment in everyday activities and psychosocial functioning is essential. Surveillance is required to ensure early diagnosis and optimal control of comorbid atonic manifestations including food allergies, allergic rhinitis and asthma. Early, aggressive intervention in childhood SADE (e.g. restoration of the skin barrier, reduction of allergen penetration and sensitisation) may prevent progression of the 'atonic march' and the consequential development of cornorbid disease. Complications of SADE may be severe, such as bacterial and viral superinfection, erythroderma, sight-threatening ophthalmological disease, growth retardation, adrenal insufficiency and substantial psychological distress. A stepwise approach to management is essential to ensure that all avenues are explored prior to initiation of potentially harmful therapeutic regimens. Exacerbating factors should be actively excluded (e.g non-compliance, use of unproven complementary remedies, secondary infection, hypersensitivity reactions to topical treatments, etc.). Active management (possibly including phototherapy or systemic immunomodulators) may be required to establish control, but may induce substantial side-effects. Patients and their families should be included as well-informed members of the therapeutic alliance, with the aim of accomplishing long-term favourable outcomes in physical as well as psychosocial dimensions.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 46 条
[1]   Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report [J].
Akdis, Cezmi A. ;
Akdis, Mubeccel ;
Bieber, Thomas ;
Bindslev-Jensen, Carsten ;
Boguniewicz, Mark ;
Eigenmann, Philippe ;
Hamid, Qutayba ;
Kapp, Alexander ;
Leung, Donald Y. M. ;
Lipozencic, Jasna K. ;
Luger, Thomas A. ;
Muraro, Antonella ;
Novak, Natalija ;
Platts-Mills, Thomas A. E. ;
Rosenwasser, Lanny ;
Scheynius, Annika ;
Simons, F. Estelle R. ;
Spergel, Jonathan ;
Turjanmaa, Kristiina ;
Wahn, Ulrich ;
Weidinger, Stefan ;
Werfel, Thomas ;
Zuberbier, Torsten .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (01) :152-169
[2]  
Amestejani M, 2012, J DRUGS DERMATOL, V11, P327
[3]  
[Anonymous], 2007, NICE CLIN GUID
[4]  
Bath-Hextall FJ, 2010, DIETARY SUPPLEMENTS
[5]   Atopy and keratoconus: a multivariate analysis [J].
Bawazeer, AM ;
Hodge, WG ;
Lorimer, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (08) :834-836
[6]  
Beltrani Vincent S, 2003, Dermatol Online J, V9, P1
[7]   Predictors of atopic dermatitis severity over time [J].
Ben-Gashir, MA ;
Seed, PT ;
Hay, RJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) :349-356
[8]  
Chang-Godinich A, MEDSCAPE
[9]  
Cunha B.A., 2011, Antibiotic essentials
[10]  
Dhar S., 2005, Indian J Dermatol, V50, P125